Eli Lilly and Company | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Eli Lilly Stock Price Prediction: Could This Biotech Giant Reach $1,850 by 2030?

Business

28 Sep, 2024

Eli Lilly Stock Price Prediction: Could This Biotech Giant Reach $1,850 by 2030?


Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right,...

Insulin Biosimilars Market Expected to Reach $5.41 Billion by 2028: Growth Driven by Rising Diabetes Prevalence

Business

27 Sep, 2024

Insulin Biosimilars Market Expected to Reach $5.41 Billion by 2028: Growth Driven by Rising Diabetes Prevalence


The insulin biosimilars market is poised for significant growth in the coming years, driven by several key factors. The global...

Market Movers: Palo Alto Networks Soars, Lowe's Drops, and Boeing Halts 777X Tests

Business

24 Aug, 2024

Market Movers: Palo Alto Networks Soars, Lowe's Drops, and Boeing Halts 777X Tests


U.S. equities were down at midday as the markets awaited clues about the future of interest rates from Federal Reserve...

Organon Expands Deal with Lilly for Migraine Treatment Emgality in 11 New Markets

Business

21 Aug, 2024

Organon Expands Deal with Lilly for Migraine Treatment Emgality in 11 New Markets


Organon, a global healthcare company focused on women’s health, has expanded its agreement with Eli Lilly and Company to become...

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack

Business

21 Aug, 2024

Top Biopharma Companies Witness 4.3% Market Cap Growth in Q2 2024, GLP-1 Innovators Lead the Pack


The global biopharmaceutical industry demonstrated resilience in the second quarter (Q2) of 2024, with the top 20 companies reporting a...

Top 20 Biopharma Companies See Market Capitalization Growth in Q2 2024: Lilly, Novo Nordisk Lead the Pack

Business

20 Aug, 2024

Top 20 Biopharma Companies See Market Capitalization Growth in Q2 2024: Lilly, Novo Nordisk Lead the Pack


The global biopharmaceutical industry demonstrated resilience in the second quarter (Q2) of 2024, with the top 20 companies reporting a...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates